发明名称 IL-8 receptor antagonists
摘要 This invention provides for a method of treating a chemokine mediated disease, wherein the chemokine is one which binds to an IL-8 alpha or beta receptor and which method comprises administering an effective amount of a compound of Formular (I) or a pharmaceuticlly acceptable salt thereof. In particular the chemokine is IL-8.
申请公布号 US6221889(B1) 申请公布日期 2001.04.24
申请号 US20000600380 申请日期 2000.07.14
申请人 SMITHKLINE BEECHAM CORPORATION 发明人 RUTLEDGE, JR. MELVIN C.;WIDDOWSON KATHERINE L.
分类号 C07D333/50;A61K31/428;A61P29/00;A61P43/00;C07D275/06;(IPC1-7):A61K31/428 主分类号 C07D333/50
代理机构 代理人
主权项
地址